Ever After Foods

growth-positive

Israeli biotech firm Ever After Foods has raised $10M in funding to accelerate the growth of its bioreactor platform, which enables cultivated meat producers to scale up manufacturing while reducing costs. The funding round included a second investment from Israeli cellular agriculture company Pluri and the Tnuva Group, which formed Ever After Foods as a joint venture in 2022. The companys technology allows for a 90% reduction in costs for its B2B clients and yields up to six times more protein and 700 times more lipids from each cell. The funding will also help the company expand into international markets.

growth-positive

Ever After Foods, a subsidiary of Pluristem Therapeutics, has successfully raised $10 million in funding from strategic partners in the US and Europe. The company offers a technological platform for the production of cultured food, a joint venture of Pluristem and Tnuva. The company has exclusive rights to use Pluristems technology and intellectual property for the development, production, and trading of cultured meat. According to the company, Ever After Foods platform can reduce production costs by more than 90%. In addition to the new investment, Pluristem has expanded the license granted to Ever After Foods to include cultured fish.

growth-positive

Ever After Foods has launched a scalable platform for the cost-effective production of cultivated meat products. They aim to overcome the challenge of scalability in the industry and reduce costs for consumers. The company is backed by the Tnuva Group. Aleph Farms is increasing production capacities by acquiring VBL Therapeutics Facility and partnering with ESCO Aster. They are working towards the commercial launch of their first product, a fine-cut farmed filet. Mosa Meat and Nutreco are collaborating to optimize cell feed and bring down costs. They have successfully formulated a cell feed with food-grade ingredients instead of pharma-grade ones. Triplebar and Umami Meats are collaborating to optimize cell lines for sustainable seafood production. Their first project is to produce cell-based Japanese eel.

growth-positive

Israeli company Plurinuva, now rebranded as Ever After Foods, has developed a facility for the production of cultured meat that can increase productivity by about 700% compared to existing platforms. The company plans to launch its first product this year and is seeking regulatory approvals. The technology allows for the growth of cells in smaller containers, reducing costs and increasing raw material production. Tnuva, a food giant, has invested $7.3 million in the joint venture with Pluristem. The partnership aims to develop cultured meat products using Pluristems cell development technologies. The companys CEO, Eyal Rosenthal, believes their method overcomes the challenges faced by the industry and can reach price parity.

growth-positive

Israeli startup Ever After Foods has developed patented technology that can transform the economics of cultivated meat by reducing capital expenditure and increasing productivity. The company uses a two-stage approach in smaller packed bed vessels, which allows for lower production costs and a 700% increase in productivity compared to other cultivated meat technology platforms. Ever After Foods plans to launch its own cultivated meat products in the US market in late 2024 and aims to license its bioreactor technology to the wider industry. The company is backed by Israeli food co Tnuva Group, which invested $7.5 million based on a $40 million pre-money valuation.